|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 自发性脑出血治疗指南美国心脏协会/美国卒中协会对医疗卫生专业人员发布的指南显示文摘目的本指南旨在为急性自发性脑出血的诊断和治疗提供最新的综合性推荐意见。方法通过Medline进行规范的文献检索,利用证据表合并资料。撰写委员会成员通过远程电信会议讨论根据资料得出的推荐意见。采用美国心脏协会卒中委员会的证据分级方案对推荐意见进行分级。由6位同行评议专家以及卒中委员会科学声明监督委员会和卒中委员会领导委员会成员对指南的草案进行发表前审阅。预期本指南在3年内完全更新。结果本文为脑出血患者的医疗诊治提供了循证指南。重点包括诊断、止血、血压管理、院内管理和护理、预防内科合并症、外科治疗、转归预测、康复、预防复发以及将来需要考虑的问题。结论脑出血是一种严重的疾病,早期积极救治可影响其转归。本指南为脑出血患者的目标导向治疗提供了一个框架。 | Lewis B. Morgenstem J. Claude Hemphill Ⅲ Craig Anderson Kyra Becker Joseph P. Broderick E. Sander Connolly Jr Steven M. Greenberg James N. Huang R. Loch Macdonald Steven R. Messe Pamela H. Mitchell Magdy Selim Rafael J. Tamargo 王玉洁(译) 王健(译) 刘相玉(译) 谢丽丽(译) | 2010 | 国际脑血管病杂志2010，，8： | 259 |
| 2 | Procalcitonin and itscomponent peptides in systemic inflammation 显示文摘 | Snide RH Jr Nylen ES Becker KL | 1997 | J InvestigMed1997，45，9： | 1 |
| 3 | Professorial Behavior Given a Stochastic Reward Structure 显示文摘 | WILLIAM E BECKER JR | 1979 | The American Economic Review1979，89，2： | 1 |
| 4 | Febuxostat,a novel nonpurine selective inhibitor of xanthine oxidase:a twenty-eight-day,multicenter,phase Ⅱ,randomized,double-blind,placebo-controlled,dose-response clinical trial examining safety and efficacy in patients with gout显示文摘 | Becker M A Schumacher H R Jr Wortmann R L | | 0，，03： | 1 |
| 5 | Procalcitonin and its component peptides in systemic inflammation: immunochemical characterization显示文摘 | Snider RH Jr Nylen ES Becker KL | 1997 | J Investig Med1997，45，9： | 1 |
| 6 | Computer-aided planning in orthognathic surgery-systematic review 显示文摘 | Haas Jr OL Becker OE de Oliveira RB | 2014 | Int J Oral Maxillofac Surg2014，44，3： | 1 |
| 7 | Cardia cancer: at- tempt at a therapeutically relevant classification 显示文摘 | Siewert JR Holscher AH Becker K | 1987 | Chirurg1987，58，1： | 1 |
| 8 | Febuxostat compared with allopurinol in patients with hyperuricemia and gout显示文摘 | Becker M A Schumacher H R Jr Wortmann R L | | 0，，23： | 1 |
| 9 | Procalcitonin and its compo- nent peptides in systemic inflammation: immunochemical charac- terization显示文摘 | Snider RH Jr Nylen ES Becker KL | 1997 | J Investig Med1997，45，9： | 1 |
| 10 | Mucoepidermoid tumors of salivary glands 显示文摘 | Stewart F W Foote F W Jr Becker W F | 1945 | Ann Surg1945，122，5： | 1 |
| 11 | Procalcitonin and its component peptides in syste mic infiammation:immunoche mica1 characterization显示文摘 | Snide RH Jr Nylen ES Becker KL | 1997 | J Investig Med1997，45，： | 1 |
| 12 | Procalciton and its component peptides in systemic inflammation; immunochemical characterization显示文摘 | Snider RH Jr Nylen ES Becker KI | | J Investig Med0，45，9： | 1 |
| 13 | Procalcitonin and its component peptides in systemic inflammation: immunochemical characterization 显示文摘 | Snider RH Jr Nylen ES Becker KI | 1997 | J Investig Med1997，45，9： | 1 |
| 14 | Subtrochanteric femur fractures: a comparison of the Zickel nail, 95 degrees blade plate, and interlocking nail 显示文摘 | Brien WW Wiss DA Becker V Jr | 1991 | J Orthop Trauma1991，5，4： | 1 |
| 15 | Subtrochanteric femur fractures:a comparison of the Zickel nail,95 degrees blade plate,and interlocking nail显示文摘 | Brien WW Wiss DA Becker V Jr | 1991 | J Orthop Trauma1991，5，4： | 1 |
| 16 | Febuxostat compared with allopurinol in patients with hyperuricemia and gout显示文摘 | Becker MA Schumacher HR Jr Wortman RL | 2005 | N Engl J Med2005，353，23： | 1 |
| 17 | Febuxostat compared with aUopurinol in patients with hyperurlcemia and gout 显示文摘 | BECKER M A SCHUMACHER H R Jr WORTMANN R L | 2005 | N Engl J IVied2005，353，23： | 1 |
| 18 | Standardization and quality control of quantitative microscopy in pathology 显示文摘 | Becker RL Jr | 1993 | J Cell Biochem Suppl1993，17，： | 1 |
| 19 | Growth and metastasis oftumor in organ culture 显示文摘 | Folkman J Long DM Jr Becker FF | 1963 | Cancer1963，16，： | 1 |
| 20 | Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: a 28-day, multicenter, phase Ⅱ, randomized, double-blind, placebo controlled dose-response clinical trial examining safety and efficacy in patients with gout 显示文摘 | BECKER M A SCHUMACHER H R Jr WORTMANN R L | 2005 | Arthritis Rheum2005，52，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员